PlainRecalls
FDA Devices Moderate Class II Terminated

Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification by light microscopy of human calretinin molecule in paraffin sections.

Reported: June 1, 2016 Initiated: March 22, 2016 #Z-1704-2016

Product Description

Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification by light microscopy of human calretinin molecule in paraffin sections.

Reason for Recall

Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.

Details

Recalling Firm
Leica Microsystems, Inc.
Units Affected
290 units
Distribution
Worldwide Distribution -- U.S., to the following states: AK, CA, FL, GA, MN, MT, NJ, OH, TX and WA; and, the country of Canada.
Location
Buffalo Grove, IL

Frequently Asked Questions

What product was recalled?
Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification by light microscopy of human calretinin molecule in paraffin sections.. Recalled by Leica Microsystems, Inc.. Units affected: 290 units.
Why was this product recalled?
Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 1, 2016. Severity: Moderate. Recall number: Z-1704-2016.